ARS Pharmaceuticals, Inc.

SPRY
$7.80 (+ $0.63 + 8.79%)
Last updated: 2026-05-21 02:48 UTC
SPRY Metrics
Exchange
🇺🇸 NASDAQ XNMS
Nasdaq/NMS (Global Market)United StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS82835W1080
CUSIP82835W108
Market Price7.8
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend Frequency N/A
P/E RatioN/A
EPS-0.81
Market Cap$1.1B
Book Value1.49
Price to Book7.684
Beta0.8
52w High18.9
52w Low6.66
Next Earnings DateN/A

ARS Pharmaceuticals, Inc. trades under ticker SPRY on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US82835W1080, CUSIP 82835W108.

About the Company
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions. The company is involved in the development of neffy, a needle-free and low-dose intranasal epinephrine nasal spray for rescue medication for people with Type I severe allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. The company was founded in 2015 and is headquartered in San Diego, California.
Price History